United States Interferon Biosimilar Market Report 2018

April 2018 | 105 pages | ID: U5F68F7903EEN
QYResearch

Abstracts

In this report, the United States Interferon Biosimilar market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Interferon Biosimilar in these regions, from 2013 to 2025 (forecast).

United States Interferon Biosimilar market competition by top manufacturers/players, with Interferon Biosimilar sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Roche
• Biosidus
• Zydus Cadila
• Nanogen
• Amega Biotech
• Rhein Minapharm Biogenetics
• PROBIOMED
• 3sbio
• Amgen
• Bayer
• Schering Plough
• Merck

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Long-lasting Type
• Ordinary Type

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hepatitis C
• Hepatitis B
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Interferon Biosimilar Market Report 2018

1 INTERFERON BIOSIMILAR OVERVIEW

1.1 Product Overview and Scope of Interferon Biosimilar
1.2 Classification of Interferon Biosimilar by Product Category
  1.2.1 United States Interferon Biosimilar Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Interferon Biosimilar Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Long-lasting Type
  1.2.4 Ordinary Type
1.3 United States Interferon Biosimilar Market by Application/End Users
  1.3.1 United States Interferon Biosimilar Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hepatitis C
  1.3.3 Hepatitis B
  1.3.4 Other
1.4 United States Interferon Biosimilar Market by Region
  1.4.1 United States Interferon Biosimilar Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Interferon Biosimilar Status and Prospect (2013-2025)
  1.4.3 Southwest Interferon Biosimilar Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Interferon Biosimilar Status and Prospect (2013-2025)
  1.4.5 New England Interferon Biosimilar Status and Prospect (2013-2025)
  1.4.6 The South Interferon Biosimilar Status and Prospect (2013-2025)
  1.4.7 The Midwest Interferon Biosimilar Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Interferon Biosimilar (2013-2025)
  1.5.1 United States Interferon Biosimilar Sales and Growth Rate (2013-2025)
  1.5.2 United States Interferon Biosimilar Revenue and Growth Rate (2013-2025)

2 UNITED STATES INTERFERON BIOSIMILAR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Interferon Biosimilar Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Interferon Biosimilar Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Interferon Biosimilar Average Price by Players/Suppliers (2013-2018)
2.4 United States Interferon Biosimilar Market Competitive Situation and Trends
  2.4.1 United States Interferon Biosimilar Market Concentration Rate
  2.4.2 United States Interferon Biosimilar Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Interferon Biosimilar Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INTERFERON BIOSIMILAR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Interferon Biosimilar Sales and Market Share by Region (2013-2018)
3.2 United States Interferon Biosimilar Revenue and Market Share by Region (2013-2018)
3.3 United States Interferon Biosimilar Price by Region (2013-2018)

4 UNITED STATES INTERFERON BIOSIMILAR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Interferon Biosimilar Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Interferon Biosimilar Revenue and Market Share by Type (2013-2018)
4.3 United States Interferon Biosimilar Price by Type (2013-2018)
4.4 United States Interferon Biosimilar Sales Growth Rate by Type (2013-2018)

5 UNITED STATES INTERFERON BIOSIMILAR SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Interferon Biosimilar Sales and Market Share by Application (2013-2018)
5.2 United States Interferon Biosimilar Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES INTERFERON BIOSIMILAR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Interferon Biosimilar Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Roche Interferon Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Biosidus
  6.2.2 Interferon Biosimilar Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Biosidus Interferon Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Zydus Cadila
  6.3.2 Interferon Biosimilar Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Zydus Cadila Interferon Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Nanogen
  6.4.2 Interferon Biosimilar Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Nanogen Interferon Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Amega Biotech
  6.5.2 Interferon Biosimilar Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amega Biotech Interferon Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Rhein Minapharm Biogenetics
  6.6.2 Interferon Biosimilar Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Rhein Minapharm Biogenetics Interferon Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 PROBIOMED
  6.7.2 Interferon Biosimilar Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 PROBIOMED Interferon Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 3sbio
  6.8.2 Interferon Biosimilar Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 3sbio Interferon Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Amgen
  6.9.2 Interferon Biosimilar Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Amgen Interferon Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Bayer
  6.10.2 Interferon Biosimilar Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Bayer Interferon Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Schering Plough
6.12 Merck

7 INTERFERON BIOSIMILAR MANUFACTURING COST ANALYSIS

7.1 Interferon Biosimilar Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Interferon Biosimilar

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Interferon Biosimilar Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Interferon Biosimilar Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INTERFERON BIOSIMILAR MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Interferon Biosimilar Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Interferon Biosimilar Sales Volume Forecast by Type (2018-2025)
11.3 United States Interferon Biosimilar Sales Volume Forecast by Application (2018-2025)
11.4 United States Interferon Biosimilar Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Interferon Biosimilar
Figure United States Interferon Biosimilar Market Size (K Units) by Type (2013-2025)
Figure United States Interferon Biosimilar Sales Volume Market Share by Type (Product Category) in 2017
Figure Long-lasting Type Product Picture
Figure Ordinary Type Product Picture
Figure United States Interferon Biosimilar Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Interferon Biosimilar by Application in 2017
Figure Hepatitis C Examples
Table Key Downstream Customer in Hepatitis C
Figure Hepatitis B Examples
Table Key Downstream Customer in Hepatitis B
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Interferon Biosimilar Market Size (Million USD) by Region (2013-2025)
Figure The West Interferon Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Interferon Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Interferon Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Interferon Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Interferon Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Interferon Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Interferon Biosimilar Sales (K Units) and Growth Rate (2013-2025)
Figure United States Interferon Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Interferon Biosimilar Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Interferon Biosimilar Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Interferon Biosimilar Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Interferon Biosimilar Sales Share by Players/Suppliers
Figure 2017 United States Interferon Biosimilar Sales Share by Players/Suppliers
Figure United States Interferon Biosimilar Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Interferon Biosimilar Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Interferon Biosimilar Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Interferon Biosimilar Revenue Share by Players/Suppliers
Figure 2017 United States Interferon Biosimilar Revenue Share by Players/Suppliers
Table United States Market Interferon Biosimilar Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Interferon Biosimilar Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Interferon Biosimilar Market Share of Top 3 Players/Suppliers
Figure United States Interferon Biosimilar Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Interferon Biosimilar Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Interferon Biosimilar Product Category
Table United States Interferon Biosimilar Sales (K Units) by Region (2013-2018)
Table United States Interferon Biosimilar Sales Share by Region (2013-2018)
Figure United States Interferon Biosimilar Sales Share by Region (2013-2018)
Figure United States Interferon Biosimilar Sales Market Share by Region in 2017
Table United States Interferon Biosimilar Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Interferon Biosimilar Revenue Share by Region (2013-2018)
Figure United States Interferon Biosimilar Revenue Market Share by Region (2013-2018)
Figure United States Interferon Biosimilar Revenue Market Share by Region in 2017
Table United States Interferon Biosimilar Price (USD/Unit) by Region (2013-2018)
Table United States Interferon Biosimilar Sales (K Units) by Type (2013-2018)
Table United States Interferon Biosimilar Sales Share by Type (2013-2018)
Figure United States Interferon Biosimilar Sales Share by Type (2013-2018)
Figure United States Interferon Biosimilar Sales Market Share by Type in 2017
Table United States Interferon Biosimilar Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Interferon Biosimilar Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Interferon Biosimilar by Type (2013-2018)
Figure Revenue Market Share of Interferon Biosimilar by Type in 2017
Table United States Interferon Biosimilar Price (USD/Unit) by Types (2013-2018)
Figure United States Interferon Biosimilar Sales Growth Rate by Type (2013-2018)
Table United States Interferon Biosimilar Sales (K Units) by Application (2013-2018)
Table United States Interferon Biosimilar Sales Market Share by Application (2013-2018)
Figure United States Interferon Biosimilar Sales Market Share by Application (2013-2018)
Figure United States Interferon Biosimilar Sales Market Share by Application in 2017
Table United States Interferon Biosimilar Sales Growth Rate by Application (2013-2018)
Figure United States Interferon Biosimilar Sales Growth Rate by Application (2013-2018)
Table Roche Basic Information List
Table Roche Interferon Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Interferon Biosimilar Sales Growth Rate (2013-2018)
Figure Roche Interferon Biosimilar Sales Market Share in United States (2013-2018)
Figure Roche Interferon Biosimilar Revenue Market Share in United States (2013-2018)
Table Biosidus Basic Information List
Table Biosidus Interferon Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biosidus Interferon Biosimilar Sales Growth Rate (2013-2018)
Figure Biosidus Interferon Biosimilar Sales Market Share in United States (2013-2018)
Figure Biosidus Interferon Biosimilar Revenue Market Share in United States (2013-2018)
Table Zydus Cadila Basic Information List
Table Zydus Cadila Interferon Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Zydus Cadila Interferon Biosimilar Sales Growth Rate (2013-2018)
Figure Zydus Cadila Interferon Biosimilar Sales Market Share in United States (2013-2018)
Figure Zydus Cadila Interferon Biosimilar Revenue Market Share in United States (2013-2018)
Table Nanogen Basic Information List
Table Nanogen Interferon Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Nanogen Interferon Biosimilar Sales Growth Rate (2013-2018)
Figure Nanogen Interferon Biosimilar Sales Market Share in United States (2013-2018)
Figure Nanogen Interferon Biosimilar Revenue Market Share in United States (2013-2018)
Table Amega Biotech Basic Information List
Table Amega Biotech Interferon Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amega Biotech Interferon Biosimilar Sales Growth Rate (2013-2018)
Figure Amega Biotech Interferon Biosimilar Sales Market Share in United States (2013-2018)
Figure Amega Biotech Interferon Biosimilar Revenue Market Share in United States (2013-2018)
Table Rhein Minapharm Biogenetics Basic Information List
Table Rhein Minapharm Biogenetics Interferon Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Rhein Minapharm Biogenetics Interferon Biosimilar Sales Growth Rate (2013-2018)
Figure Rhein Minapharm Biogenetics Interferon Biosimilar Sales Market Share in United States (2013-2018)
Figure Rhein Minapharm Biogenetics Interferon Biosimilar Revenue Market Share in United States (2013-2018)
Table PROBIOMED Basic Information List
Table PROBIOMED Interferon Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure PROBIOMED Interferon Biosimilar Sales Growth Rate (2013-2018)
Figure PROBIOMED Interferon Biosimilar Sales Market Share in United States (2013-2018)
Figure PROBIOMED Interferon Biosimilar Revenue Market Share in United States (2013-2018)
Table 3sbio Basic Information List
Table 3sbio Interferon Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure 3sbio Interferon Biosimilar Sales Growth Rate (2013-2018)
Figure 3sbio Interferon Biosimilar Sales Market Share in United States (2013-2018)
Figure 3sbio Interferon Biosimilar Revenue Market Share in United States (2013-2018)
Table Amgen Basic Information List
Table Amgen Interferon Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Interferon Biosimilar Sales Growth Rate (2013-2018)
Figure Amgen Interferon Biosimilar Sales Market Share in United States (2013-2018)
Figure Amgen Interferon Biosimilar Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Interferon Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Interferon Biosimilar Sales Growth Rate (2013-2018)
Figure Bayer Interferon Biosimilar Sales Market Share in United States (2013-2018)
Figure Bayer Interferon Biosimilar Revenue Market Share in United States (2013-2018)
Table Schering Plough Basic Information List
Table Merck Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Interferon Biosimilar
Figure Manufacturing Process Analysis of Interferon Biosimilar
Figure Interferon Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Interferon Biosimilar Major Players/Suppliers in 2017
Table Major Buyers of Interferon Biosimilar
Table Distributors/Traders List
Figure United States Interferon Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Interferon Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Interferon Biosimilar Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Interferon Biosimilar Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Interferon Biosimilar Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Interferon Biosimilar Sales Volume (K Units) Forecast by Type in 2025
Table United States Interferon Biosimilar Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Interferon Biosimilar Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Interferon Biosimilar Sales Volume (K Units) Forecast by Application in 2025
Table United States Interferon Biosimilar Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Interferon Biosimilar Sales Volume Share Forecast by Region (2018-2025)
Figure United States Interferon Biosimilar Sales Volume Share Forecast by Region (2018-2025)
Figure United States Interferon Biosimilar Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources